Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 15651-15700 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT03570606
Clinical Study of Bone Graft Substitutes in Orthopaedic and Spinal Applications.
N/A
Active, not recruiting
220 participants
Started: Jun 13, 2019 · Completed: Jun 30, 2026
1 condition
1 sponsor
7 locations
NCT06808672
Biomarkers of Cancer-Associated Myositis
N/A
Active, not recruiting
50 participants
Started: Jun 13, 2019 · Completed: Dec 31, 2025
1 condition
1 sponsor
2 locations
NCT03924856
Perioperative Pembrolizumab (MK-3475) Plus Neoadjuvant Chemotherapy Versus Perioperative Placebo Plus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle-invasive Bladder Cancer (MIBC) (MK-3475-866/KEYNOTE-866)
PHASE3
Active, not recruiting
907 participants
Started: Jun 13, 2019 · Completed: Sep 1, 2026
1 condition
1 sponsor
175 locations
NCT04005521
Randomized Study Regarding Preventive Jaw- and Swallowing Intervention for Patients with Head and Neck Cancer
NA
Active, not recruiting
80 participants
Started: Jun 13, 2019 · Completed: Jul 31, 2028
3 conditions
1 sponsor
1 location
NCT03571191
Denosumab Treatment for Fibrous Dysplasia
PHASE2
Active, not recruiting
9 participants
Started: Jun 13, 2019 · Completed: Mar 15, 2030
2 conditions
1 sponsor
1 location
NCT05421442
A Post-marketing Study on the Safety of Abatacept Treatment in Denmark Using the Danish Database
N/A
Active, not recruiting
1,450 participants
Started: Jun 13, 2019 · Completed: Jan 30, 2026
2 conditions
1 sponsor
1 location
NCT03988595
Exercise Treatment With Standard Therapy for Metastatic Breast Cancer
PHASE1
Active, not recruiting
54 participants
Started: Jun 12, 2019 · Completed: Aug 1, 2026
1 condition
1 sponsor
10 locations
NCT03989947
An Extension Study to Evaluate Safety and Efficacy of BMN 111 in Children With Achondroplasia
PHASE2
Active, not recruiting
73 participants
Started: Jun 12, 2019 · Completed: May 31, 2038
1 condition
1 sponsor
16 locations
NCT03865212
Modified Virus VSV-IFNbetaTYRP1 in Treating Patients With Stage III-IV Melanoma
PHASE1
Active, not recruiting
12 participants
Started: Jun 12, 2019 · Completed: Jan 20, 2027
13 conditions
1 sponsor
2 locations
NCT03972930
Hypofractionated Radiotherapy for Soft Tissue Sarcomas
PHASE2
Active, not recruiting
48 participants
Started: Jun 11, 2019 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT03999749
A Phase II Study of the Interleukin-6 Receptor Inhibitor Tocilizumab in Combination With Ipilimumab and Nivolumab in Patients With Unresectable Stage III or Stage IV Melanoma
PHASE2
Active, not recruiting
71 participants
Started: Jun 11, 2019 · Completed: Apr 7, 2030
1 condition
1 sponsor
4 locations
NCT03767244
A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy
PHASE3
Active, not recruiting
2,517 participants
Started: Jun 11, 2019 · Completed: Jul 19, 2029
1 condition
1 sponsor
202 locations
NCT04089215
CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Non-Hodgkins Lymphoma
PHASE2
Active, not recruiting
82 participants
Started: Jun 11, 2019 · Completed: Sep 30, 2024
3 conditions
1 sponsor
10 locations
NCT03992417
Observational Study of Patients Receiving Dupixent® for Atopic Dermatitis (AD)
N/A
Active, not recruiting
955 participants
Started: Jun 11, 2019 · Completed: Mar 31, 2027
1 condition
2 sponsors
114 locations
NCT03985176
Delayed Cerebral Ischaemia and Coagulation Alterations After Aneurysmal Subarachnoid Haemorrhage
N/A
Active, not recruiting
62 participants
Started: Jun 10, 2019 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT03973372
ALTA TIPS: A 5-year Longitudinal Observational Study of Patients Undergoing TIPS Placement
N/A
Active, not recruiting
852 participants
Started: Jun 10, 2019 · Completed: Dec 31, 2027
2 conditions
16 sponsors
14 locations
NCT03735667
ACURATE IDE: Safety and Effectiveness Study of ACURATE Valve for Transcatheter Aortic Valve Replacement
NA
Active, not recruiting
1,948 participants
Started: Jun 10, 2019 · Completed: Sep 30, 2034
1 condition
1 sponsor
75 locations
NCT03975907
Clinical Trial to Evaluate CT053 in Patients With Relapsed and/or Refractory Multiple Myeloma (LUMMICAR STUDY 1)
PHASE1/PHASE2
Active, not recruiting
121 participants
Started: Jun 10, 2019 · Completed: Dec 31, 2025
1 condition
14 sponsors
23 locations
NCT03741101
Treatment of NF1-related Plexiform Neurofibroma With Trametinib
PHASE2
Active, not recruiting
15 participants
Started: Jun 10, 2019 · Completed: Dec 15, 2024
3 conditions
2 sponsors
1 location
NCT03911557
Durvalumab and Tremelimumab Combination in Somatically Hypermutated Recurrent Solid Tumors
PHASE2
Active, not recruiting
14 participants
Started: Jun 8, 2019 · Completed: Oct 31, 2025
1 condition
1 sponsor
1 location
NCT03839342
Binimetinib and Encorafenib for the Treatment of Advanced Solid Tumors With Non-V600E BRAF Mutations
PHASE2
Active, not recruiting
26 participants
Started: Jun 7, 2019 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT03627988
Prospective, Multicentric Study Evaluating the Surgical Treatment by Mastectomy With Immediate Prosthetic Breast Reconstruction in Patients With Breast Cancer and Receiving Adjuvant Therapy by TomoTherapy +/-Chemotherapy.
PHASE2
Active, not recruiting
65 participants
Started: Jun 7, 2019 · Completed: May 31, 2026
1 condition
1 sponsor
2 locations
NCT03793166
Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study
PHASE3
Active, not recruiting
1,175 participants
Started: Jun 7, 2019 · Completed: Sep 15, 2026
9 conditions
1 sponsor
864 locations
NCT03943173
Olaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cancer Before Surgery
EARLY_PHASE1
Active, not recruiting
15 participants
Started: Jun 7, 2019 · Completed: Dec 27, 2025
31 conditions
2 sponsors
1 location
NCT03965325
FOcUs on Colorectal CAncer oUtcomes: Long-Term Study
N/A
Active, not recruiting
133 participants
Started: Jun 7, 2019 · Completed: Jun 6, 2025
1 condition
1 sponsor
1 location
NCT04040530
Patient Reported Outcome After Nephron Sparing Treatment of Small Renal Tumours
N/A
Active, not recruiting
187 participants
Started: Jun 7, 2019 · Completed: Feb 7, 2026
2 conditions
3 sponsors
2 locations
NCT04088292
Low Dose Thrombolysis, Ultrasound Assisted Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism
PHASE3
Active, not recruiting
210 participants
Started: Jun 6, 2019 · Completed: Nov 30, 2024
1 condition
5 sponsors
4 locations
NCT03779711
Intramyocardial Injection of Autologous Umbilical Cord Blood Derived Mononuclear Cells During Surgical Repair of Hypoplastic Left Heart Syndrome
PHASE2
Active, not recruiting
95 participants
Started: Jun 6, 2019 · Completed: Feb 28, 2026
1 condition
9 sponsors
8 locations
NCT03957252
Validation of ClarityDX Prostate as a Reflex Test to Refine the Prediction of Clinically-significant Prostate Cancer
N/A
Active, not recruiting
2,800 participants
Started: Jun 6, 2019 · Completed: Mar 31, 2027
1 condition
9 sponsors
3 locations
NCT03625752
Optimization of NIBS for Diabetic Neuropathy Neuropathic Pain
NA
Active, not recruiting
60 participants
Started: Jun 6, 2019 · Completed: May 7, 2026
2 conditions
2 sponsors
2 locations
NCT04302220
Myopic Optic Neuropathy in Chinese High Myopia Population
N/A
Active, not recruiting
813 participants
Started: Jun 6, 2019 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT03923270
Radiotherapy and Durvalumab/Durvalumab Combo (Tremelimumab/Olaparid) for Small Cell Lung Cancer
PHASE1
Active, not recruiting
25 participants
Started: Jun 6, 2019 · Completed: Dec 31, 2025
2 conditions
2 sponsors
1 location
NCT04870866
NAD Supplementation to Prevent Progressive Neurological Disease in Ataxia Telangiectasia
PHASE2
Active, not recruiting
13 participants
Started: Jun 5, 2019 · Completed: Jun 16, 2027
1 condition
9 sponsors
2 locations
NCT03959215
Back in the Game: a Smartphone Application to Support Athletes Returning to Sport After Serious Injury
NA
Active, not recruiting
169 participants
Started: Jun 5, 2019 · Completed: Jul 31, 2024
1 condition
6 sponsors
7 locations
NCT03598309
Phase II Trial to Modulate Intermediate Endpoint Biomarkers in Former and Current Smokers
PHASE2
Active, not recruiting
19 participants
Started: Jun 5, 2019 · Completed: May 31, 2026
2 conditions
2 sponsors
1 location
NCT03766009
Increasing Patients' Engagement in Breast Cancer Surgery Decision-Making
NA
Active, not recruiting
627 participants
Started: Jun 5, 2019 · Completed: Dec 15, 2026
4 conditions
3 sponsors
58 locations
NCT03889795
Phase IB Metformin, Digoxin, Simvastatin in Solid Tumors
PHASE1
Active, not recruiting
15 participants
Started: Jun 5, 2019 · Completed: Dec 30, 2027
2 conditions
1 sponsor
1 location
NCT03719131
Rituximab and Hyaluronidase Human in Patients With Advanced Melanoma Undergoing Nivolumab and Ipilimumab Therapy
PHASE2
Active, not recruiting
15 participants
Started: Jun 5, 2019 · Completed: Jun 30, 2026
8 conditions
2 sponsors
1 location
NCT03612232
Cabozantinib in Advanced Adrenocortical Carcinoma
PHASE2
Active, not recruiting
37 participants
Started: Jun 4, 2019 · Completed: Apr 30, 2025
1 condition
1 sponsor
2 locations
NCT03969004
Study of Adjuvant Cemiplimab Versus Placebo After Surgery and Radiation Therapy in Patients With High Risk Cutaneous Squamous Cell Carcinoma
PHASE3
Active, not recruiting
415 participants
Started: Jun 4, 2019 · Completed: Mar 26, 2028
1 condition
1 sponsor
166 locations
NCT03727880
Study of Pembrolizumab With or Without Defactinib Following Chemotherapy as a Neoadjuvant and Adjuvant Treatment for Resectable Pancreatic Ductal Adenocarcinoma
PHASE2
Active, not recruiting
36 participants
Started: Jun 4, 2019 · Completed: Jan 15, 2026
2 conditions
3 sponsors
3 locations
NCT03915951
An Open-label Study of Encorafenib + Binimetinib in Patients With BRAFV600-mutant Non-small Cell Lung Cancer
PHASE2
Active, not recruiting
98 participants
Started: Jun 4, 2019 · Completed: Oct 30, 2025
1 condition
1 sponsor
159 locations
NCT03964311
Risk for Short-term Adverse Events in Older Emergency Department Users
NA
Active, not recruiting
5,000 participants
Started: Jun 4, 2019 · Completed: Jan 1, 2025
4 conditions
1 sponsor
1 location
NCT03995966
A Clinical Trial for Self-Injurious Behavior
NA
Active, not recruiting
16 participants
Started: Jun 4, 2019 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT03913949
A Study to Evaluate the Safety,PK and PD of APG-2575 in Patients With Hematologic Malignancies
PHASE1
Active, not recruiting
74 participants
Started: Jun 3, 2019 · Completed: Dec 31, 2025
2 conditions
2 sponsors
5 locations
NCT03924219
CMV T Cell Immunity in Pediatric Solid Organ Transplant Recipients
N/A
Active, not recruiting
120 participants
Started: Jun 3, 2019 · Completed: Jul 31, 2025
4 conditions
2 sponsors
12 locations
NCT03568383
Protecting Households On Exposure to Newly Diagnosed Index Multidrug-Resistant Tuberculosis Patients
PHASE3
Active, not recruiting
5,832 participants
Started: Jun 3, 2019 · Completed: Jan 11, 2027
1 condition
3 sponsors
31 locations
NCT03775265
Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer
PHASE3
Active, not recruiting
475 participants
Started: Jun 3, 2019 · Completed: Jun 1, 2027
4 conditions
1 sponsor
366 locations
NCT03907735
Oxytocin Receptor Expression in Pregnancy
N/A
Active, not recruiting
30 participants
Started: Jun 3, 2019 · Completed: Aug 31, 2025
2 conditions
1 sponsor
1 location
NCT03677739
Young Melanoma Family Facebook Intervention or Healthy Lifestyle Facebook Intervention in Improving Skin Examination in Participants With Melanoma and Their Families
NA
Active, not recruiting
1,160 participants
Started: Jun 3, 2019 · Completed: Dec 31, 2025
22 conditions
2 sponsors
2 locations
Previous
1
More pages
311
312
313
314
315
316
317
More pages
431
Next